Already have an account?


Login with an existing Projects In Knowledge account
New to Projects In Knowledge?


Register today to customize your experience.
Log In
Don't have an account yet? Click here to register



Register for Free
Already have an account? Click here to log in



Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.



Forgot Password

Please Enter your email address.




  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy
www.projectsinknowledge.com is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of projectsinknowledge.com is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

Listserves
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact privacy@projectsinknowledge.com.

Revision date: This policy was last updated on September 30, 2003.



New and Noteworthy
Education Initiative in Infectious Diseases

  • Hepatitis C — Chapter 4.3: Upcoming Management Strategies for Treatment of Nonresponder and Interferon-Ineligible/Intolerant Patients – @Point of Care Chapter
  • All-oral antiviral treatments for chronic hepatitis C are more effective and tolerable than interferon-based regimens and have improved prospects for treatment success in previously difficult-to-treat patient populations. Join Dr. Nancy S. Reau as she gives an overview of new standard-of-care therapies as ... more >>
    P. Kwo, MD
  • Hepatitis C — Chapter 4.4: Challenges and Opportunities in the Management of HCV Genotype 3 – @Point of Care Chapter
  • This subchapter briefly discusses the epidemiology and biology of hepatitis C genotype 3, and then reviews the current standard of therapy for genotype 3 and clinical trial data for new and emerging agents. Throughout the chapter you will find tables, audio commentary, and hyperlinks to enhance your ... more >>
    P. Kwo, MD
  • Hepatitis C — Epidemiology of HCV: Current and Future Perspectives – @Point of Care Chapter
  • The first chapter of the Hepatitis C @Point of Care program discusses epidemiologic data as well as the cost of the disease and the health burden. Throughout this chapter, you will find hyperlinks and other interactive resources that will help enhance your understanding of relevant issues. An increased ... more >>
    P. Kwo, MD
  • Hepatitis C — Etiology and Pathophysiology of HCV – @Point of Care Chapter
  • Chapter 2 covers the etiology and pathophysiology of hepatitis C virus and focuses on the relationships among the immune response, inflammation, and the development of long-term complications, the contributions of the virus and the immune system, and the implications for therapy. Throughout this chapter, you ... more >>
    P. Kwo, MD
  • Hepatitis C — Emerging Antiviral Agents and Strategies – @Point of Care Chapter
  • Oral interferon-free regimens will be the standard-of-care therapy for chronic hepatitis C virus (HCV) genotype-1 infection within the next year. Join Dr. Robert G. Gish as he gives an overview of the efficacy and safety of these emerging regimens and what these new options mean for your patients. Throughout ... more >>
    P. Kwo, MD
  • Hepatitis C — HCV Case Study: HCV Therapy for a Treatment-Experienced Noncirrhotic Patient with HCV Genotype-1a Infection and the Q80K Polymorphism – Case Study
  • Emerging interferon-free therapies will offer a variety of treatment options for patients with hepatitis C genotype-1 infection. The challenge for the clinician will be to evaluate patient-specific factors in order to select the regimen most likely to achieve sustained virologic response. Join Mark S. ... more >>
    M. Sulkowski, MD
  • Hepatitis C — HCV Case Study: HCV Therapy for a Genotype-1b Patient Intolerant to IFN-Based Therapies – Case Study
  • Emerging interferon-free regimens will offer treatment options to patients who have had prior nonresponse or intolerable adverse effects with peginterferon/ribavirin. Phase III testing of these regimens have evaluated efficacy in various patient subgroups, including HCV genotype subtypes, in order to ... more >>
    M. Sulkowski, MD
  • Hepatitis C — HCV Case Study: HCV Therapy for a Prior Partial Responder with Genotype-1 HCV Infection – Case Study
  • Multiple new therapeutic options for the treatment of chronic hepatitis C virus infection allows selection based on multiple factors, including trial data, comorbidities, and patient preferences. Join Zobair M. Younossi, MD, MPH, for this case study in which he discusses the treatment decision for a prior ... more >>
    Z. Younossi, MD, MPH, FACG
  • Hepatitis C — Hepatitis C Treatment Goes Viral: Let's Talk About Oral Therapies – Webcast
  • This compelling webcast features expert-guided presentations on the current state of oral therapies for chronic hepatitis C virus (HCV) infection. Learn the implications of clinical trial results, and how the latest advances are affecting today's real-world clinical practice.
    I. Jacobson, MD
  • Hepatitis C — HCV Case Study: HCV Therapy for a Treatment-Naive Patient with Genotype-1 HCV Infection and Compensated Cirrhosis – Case Study
  • Recently approved direct-acting antiviral agents offer new choices for patients with chronic hepatitis C virus infection, including those with cirrhosis. Join Paul Y. Kwo, MD, for this case study in which he follows a cirrhotic treatment-naive patient with genotype-1b infection from assessment through ... more >>
    P. Kwo, MD
  • Curriculum In Context: Hepatitis C Virus

  • Curriculum In Context: Hepatitis C Virus (HCV) is designed to provide up-to-date information on patient identification, symptoms, risk factors, and current and emerging treatments and best practices in the management of HCV. The curriculum includes six case studies at the point of care and MedPage Today ...
    more >>
    P. Kwo, MD
    Z. Younossi, MD, MPH, FACG
  • HCV Care and Guidance
    Practical Education and Resources
  • Now in its second year and with an expanded curriculum, HCV Care & Guidance: Practical Education and Resources continues to guide your staff in the optimal use of new direct-acting antiviral (DAA) therapies in treating your patients with chronic hepatitis C virus (HCV) infection.

    In May 2011, the FDA ...
    more >>
    T. Taskaya, PA-C, CCRC
  • Chronic Hepatitis B: The Advanced Curriculum
  • Adrian M. Di Bisceglie, MD, FACP, and Robert G. Gish, MD, co-chair this free, long-form CME/CE curriculum featuring new and engaging courses that offer the latest information and case discussions on topics such as screening, current and emerging treatment strategies, IL28, HCC, renal dysfunction, and ... more >>
    A. Di Bisceglie, MD, FACP
    R. Gish, MD
  • HCV Video Case Vignettes
  • This Point-of-Care clinical companion focuses on the new treatment paradigm for hepatitis C virus (HCV) infection - €”direct-acting antiviral (DAA) agents - €”through a collection of case-based video vignettes.
    S. Flamm, MD
    Z. Younossi, MD, MPH, FACG
  • The Advanced Certificate Program in Chronic Hepatitis B Management VI: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities
  • Adrian M. Di Bisceglie, MD, FACP, and Robert G. Gish, MD, co-chair this free, long-form CME/CE program featuring the very latest information on screening and current and emerging treatment strategies for HBV management. Get clarity and guidance from prominent hepatology experts on key issues and practice ... more >>
    A. Di Bisceglie, MD, FACP
    R. Gish, MD
  • Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities
  • Adrian M. Di Bisceglie, MD, FACP, and Robert G. Gish, MD, co-chair this free, yearlong CME/CE program featuring the very latest information on screening and current and emerging treatment strategies for HBV management. Get clarity and guidance from prominent hepatology experts on key issues and practice ... more >>
    A. Di Bisceglie, MD, FACP
    R. Gish, MD
  • The Advanced Certificate Program in Chronic Hepatitis B Management IV
  • Projects In Knowledge is pleased to present The Advanced Certificate Program in Chronic Hepatitis B Mangement IV: Bridging Cultural Differences to Improve HBV Treatment in Asian and Other Diverse Communities.

    This year's state-of-the-science curriculum features the very latest information on screening and ...
    more >>
    A. Di Bisceglie, MD, FACP
    R. Gish, MD
  • Practical Education and Resources
  • This robust point-of-care eHandbook provides practical guidance on direct-acting antiviral (DAA) agents and other new therapeutic options for hepatitis C virus (HCV) infection that will help you improve patient care and outcomes. Get valuable information on patient preparation, office flow, side-effect management, treatment adherence, and monitoring. Each of the six chapters also includes hyperlinks to additional multimedia resources that enhance understanding of relevant issues.
    S. Brinkley, MSN, CRNP
    J. Chang, PA-C
    C. Levine, PhD, FNP
    T. Taskaya, PA-C, CCRC
  • Hepatitis C — Hepatitis C Treatment Goes Viral: Let's Talk About Oral Therapies – Webcast
  • This compelling webcast features expert-guided presentations on the current state of oral therapies for chronic hepatitis C virus (HCV) infection. Learn the implications of clinical trial results, and how the latest advances are affecting today's real-world clinical practice.
    I. Jacobson, MD
  • Hepatitis C — DAA Treatment: A Guide for Managing the HCV Epidemic – Webcast
  • It's been a year of game-changing therapy for HCV patients. But the benefits of treatment can only be achieved for those diagnosed. Don't miss out on what these experts have to say.
    I. Jacobson, MD
  • Hepatitis C — Paradigm Shift in HCV Standard of Care Treatment: DAAs – On Demand Webcast
  • The two newly approved direct-acting antiviral (DAA) therapies are dramatically changing the HCV treatment landscape. Through presentations and case vignettes, our expert faculty will show you why and how you should integrate the new DAA therapies into your clinical practice.
    I. Jacobson, MD
    D. Nelson, MD
  • Hepatitis C — Hepatitis C: The Next Opportunity for the HIV Treater – Webcast
  • In this on-demand webcast, HIV treaters learn how their current expertise in complex viral infections and related public health concerns, combined with new knowledge about emerging direct-acting antiviral therapies and other exciting approaches for treating hepatitis C, are creating important opportunities ... more >>
    M. Sulkowski, MD
  • Hepatitis C — Social Media, HCV, and the Gastroenterologist – On Demand Webcast
  • How will scientific and digital advances revolutionize your practice? Join us for a symposium that will explore how the advances now changing the world will transform the practice of gastroenterology and the management of chronic hepatitis C. Dr. Bryan S. Vartabedian, an expert on healthcare and social media, ... more >>
    I. Jacobson, MD
  • Hepatitis C — Game Changers in Hepatology—Future Challenges in the Treatment of HCV – On Demand Webcast
  • What will your practice look like in the coming years? Watch Game Changers in Hepatology—Future Challenges in the Treatment of HCV an on-demand rebroadcast of a recent CME/CE satellite symposium, chaired by Dr. Ira Jacobson, during which Rosemarie Nelson, a nationally known healthcare consultant, will ... more >>
    I. Jacobson, MD
  • Hepatitis C — Brainstorming with the Experts: Practical Approaches to the Complex World of HCV – Webcast
  • This stimulating and thought-provoking webcast features a renowned faculty panel—led by Ira Jacobson, MD—who shape their experience and the latest research data into presentations that clarify the state of the science. Moderating is Ira Flatow, host of Talk of the Nation: Science Friday® on National ... more >>
    I. Flatow,
    I. Jacobson, MD
  • Hepatitis C — HCV Case Study: HCV Therapy for a Treatment-Experienced Noncirrhotic Patient with HCV Genotype-1a Infection and the Q80K Polymorphism – Case Study
  • Emerging interferon-free therapies will offer a variety of treatment options for patients with hepatitis C genotype-1 infection. The challenge for the clinician will be to evaluate patient-specific factors in order to select the regimen most likely to achieve sustained virologic response. Join Mark S. ... more >>
    M. Sulkowski, MD
  • Hepatitis C — HCV Case Study: HCV Therapy for a Genotype-1b Patient Intolerant to IFN-Based Therapies – Case Study
  • Emerging interferon-free regimens will offer treatment options to patients who have had prior nonresponse or intolerable adverse effects with peginterferon/ribavirin. Phase III testing of these regimens have evaluated efficacy in various patient subgroups, including HCV genotype subtypes, in order to ... more >>
    M. Sulkowski, MD
  • Hepatitis C — HCV Case Study: HCV Therapy for a Prior Partial Responder with Genotype-1 HCV Infection – Case Study
  • Multiple new therapeutic options for the treatment of chronic hepatitis C virus infection allows selection based on multiple factors, including trial data, comorbidities, and patient preferences. Join Zobair M. Younossi, MD, MPH, for this case study in which he discusses the treatment decision for a prior ... more >>
    Z. Younossi, MD, MPH, FACG
  • Hepatitis C — HCV Case Study: HCV Therapy for a Treatment-Naive Patient with Genotype-1 HCV Infection and Compensated Cirrhosis – Case Study
  • Recently approved direct-acting antiviral agents offer new choices for patients with chronic hepatitis C virus infection, including those with cirrhosis. Join Paul Y. Kwo, MD, for this case study in which he follows a cirrhotic treatment-naive patient with genotype-1b infection from assessment through ... more >>
    P. Kwo, MD
  • Hepatitis C — HCV Case Study: Interferon-Free Oral Anti-HCV Therapy in an Infected Genotype 1a-Infected Patient with Prior Null Response to Peginterferon/Ribavirin Combination Therapy – Case Study
  • Phase II data from emerging all-oral direct-acting antiviral regimens show high rates of sustained virologic response (SVR), even in patients with prior null response to peginterferon-based therapy. Join Paul Y. Kwo, MD, for this case study in which he identifies a null responder who elects to enroll in a ... more >>
    P. Kwo, MD
  • Hepatitis C — HCV Case Study: Interferon-Free Oral Anti-HCV Therapy in a Treatment-Naive Patient with Genotype-1 Infection – Case Study
  • Interferon-free combination regimens that include all-oral direct-acting antivirals (DAA) from multiple classes have demonstrated sustained virologic response rates exceeding 90% in phase II testing among treatment-naive patients infected with genotype-1 hepatitis C virus. In this case study, Zobair M. ... more >>
    Z. Younossi, MD, MPH, FACG
  • Hepatitis B — Video Case Study 4: Guidance and Insights for Managing Your Patients with HBV Treating HBV Patients with Renal Insufficiency – Video Case Vignette
  • The management of antiviral therapy in HBV patients with renal insufficiency presents several challenges to the clinician, including the cause of decreased renal function, appropriate treatment selection, and ongoing monitoring of renal function. Join Dr. Kris Kowdley as he presents a case that provides ... more >>
    K. Kowdley, MD
  • Hepatitis B — Case Study: Treatment-Experienced Patient on Long-Term Suboptimal Therapy: Why and How to Switch – Tx Reporter e-Newsletter
  • The management of chronic hepatitis B is a long-term commitment. The clinician is involved not only at the time of diagnosis and initial treatment choices but on an ongoing basis to monitor treatment and interpret virologic, serologic, and biochemical responses as well as adverse effects. Making the decision ... more >>
    A. Di Bisceglie, MD, FACP
  • Hepatitis B — Video Case Study 3: Guidance and Insights for Managing Your Patients with HBV - Acute Hepatitis B Infection – Video Case Vignette
  • Although acute HBV infection in immunocompetent adults resolves spontaneously in approximately 95% of patients, a small percentage of individuals develop fulminant hepatic liver failure that can result in death. Therefore, identifying and treating patients at risk of poor outcomes is critical. However, it can ... more >>
    H. Te, MD
  • Hepatitis B — Video Case Study 2: Guidance and Insights for Managing Your Patients with HBV -Who to Treat and Who Not to Treat – Video Case Vignette
  • Despite the availability of treatment guidelines to assist in making clinical decisions, determining whether and/or when to begin treatment in patients with chronic HBV is not always clear, particularly in those who do not fall easily into treatment guidelines categories. In this video presentation, Dr. Di ... more >>
    A. Di Bisceglie, MD, FACP